

<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="vnda-20190630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccountsPayableAndAccruedLiabilitiesDetail" xlink:href="vnda-20190630.xsd#AccountsPayableAndAccruedLiabilitiesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="vnda-20190630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncome" xlink:href="vnda-20190630.xsd#AccumulatedOtherComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#AccumulatedOtherComprehensiveIncomeAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeSummaryOfAccumulatedBalancesRelatedToEachComponentOfOtherComprehensiveIncomeLossDetail" xlink:href="vnda-20190630.xsd#AccumulatedOtherComprehensiveIncomeSummaryOfAccumulatedBalancesRelatedToEachComponentOfOtherComprehensiveIncomeLossDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:href="vnda-20190630.xsd#AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/BusinessOrganizationAndPresentation" xlink:href="vnda-20190630.xsd#BusinessOrganizationAndPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/BusinessOrganizationAndPresentationDetail" xlink:href="vnda-20190630.xsd#BusinessOrganizationAndPresentationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingencies" xlink:href="vnda-20190630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesCftrActivatorsAndInhibitorsAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesCftrActivatorsAndInhibitorsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesFanaptAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesFanaptAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesHetliozAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesHetliozAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesResearchAndDevelopmentAndMarketingAgreementsDetails" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesResearchAndDevelopmentAndMarketingAgreementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesSummaryOfNoncanellableLongTermContractualCashObligationsDetail" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesSummaryOfNoncanellableLongTermContractualCashObligationsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesTables" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesTradipitantAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesTradipitantAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesVqw765AdditionalInformationDetail" xlink:href="vnda-20190630.xsd#CommitmentsAndContingenciesVqw765AdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="vnda-20190630.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="vnda-20190630.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="vnda-20190630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityUnaudited" xlink:href="vnda-20190630.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersEquityUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:href="vnda-20190630.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="vnda-20190630.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CoverPage" xlink:href="vnda-20190630.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/EarningsPerShare" xlink:href="vnda-20190630.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/EarningsPerShareDetail" xlink:href="vnda-20190630.xsd#EarningsPerShareDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/EarningsPerShareTables" xlink:href="vnda-20190630.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/FairValueMeasurements" xlink:href="vnda-20190630.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/FairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="vnda-20190630.xsd#FairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IncomeTaxes" xlink:href="vnda-20190630.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssets" xlink:href="vnda-20190630.xsd#IntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#IntangibleAssetsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsFanaptAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#IntangibleAssetsFanaptAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsHetliozAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#IntangibleAssetsHetliozAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsSummaryOfFutureIntangibleAssetAmortizationDetail" xlink:href="vnda-20190630.xsd#IntangibleAssetsSummaryOfFutureIntangibleAssetAmortizationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" xlink:href="vnda-20190630.xsd#IntangibleAssetsSummaryOfIntangibleAssetsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsTables" xlink:href="vnda-20190630.xsd#IntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/Inventory" xlink:href="vnda-20190630.xsd#Inventory" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/InventoryDetail" xlink:href="vnda-20190630.xsd#InventoryDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/InventoryTables" xlink:href="vnda-20190630.xsd#InventoryTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/Leases" xlink:href="vnda-20190630.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/LeasesAdditionalInformationDetails" xlink:href="vnda-20190630.xsd#LeasesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/LeasesLeaseAssetsAndLiabilitiesDetails" xlink:href="vnda-20190630.xsd#LeasesLeaseAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/LeasesMaturitiesDetails" xlink:href="vnda-20190630.xsd#LeasesMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/LeasesMaturitiesUnderAsc840Details" xlink:href="vnda-20190630.xsd#LeasesMaturitiesUnderAsc840Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/LeasesTables" xlink:href="vnda-20190630.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/LegalMatters" xlink:href="vnda-20190630.xsd#LegalMatters" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/MarketableSecurities" xlink:href="vnda-20190630.xsd#MarketableSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/MarketableSecuritiesAvailableForSaleMarketableSecuritiesDetail" xlink:href="vnda-20190630.xsd#MarketableSecuritiesAvailableForSaleMarketableSecuritiesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/MarketableSecuritiesTables" xlink:href="vnda-20190630.xsd#MarketableSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/PublicOfferingOfCommonStock" xlink:href="vnda-20190630.xsd#PublicOfferingOfCommonStock" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/PublicOfferingOfCommonStockDetail" xlink:href="vnda-20190630.xsd#PublicOfferingOfCommonStockDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensation" xlink:href="vnda-20190630.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationBlackScholesMertonOptionPricingModelForStockOptionsGrantedDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationBlackScholesMertonOptionPricingModelForStockOptionsGrantedDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationRsuAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationRsuAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationStockBasedCompensationAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationStockOptionAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationStockOptionAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationSummaryOfOptionActivityFor2006PlanAnd2016PlanDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationSummaryOfOptionActivityFor2006PlanAnd2016PlanDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationSummaryOfRsuActivityPlanDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationSummaryOfRsuActivityPlanDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationTables" xlink:href="vnda-20190630.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/StockBasedCompensationTotalStockBasedCompensationExpenseDetail" xlink:href="vnda-20190630.xsd#StockBasedCompensationTotalStockBasedCompensationExpenseDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesNetSalesByProductDetail" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPoliciesNetSalesByProductDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsDetails" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesSupplementalCashFlowsInformationDetails" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPoliciesSupplementalCashFlowsInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="vnda-20190630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/Tables" xlink:href="vnda-20190630.xsd#Tables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccountsPayableAndAccruedLiabilities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccountsPayableAndAccruedLiabilitiesDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_DD3D2EAE2F5FC80B263EDDD3F715E9F7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8A8FD6D69EB17DA5A96ADDD3F713F546" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_DD3D2EAE2F5FC80B263EDDD3F715E9F7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8A8FD6D69EB17DA5A96ADDD3F713F546" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_99D41D6E44302B6CA46CDDD3F7136937" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8A8FD6D69EB17DA5A96ADDD3F713F546" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_99D41D6E44302B6CA46CDDD3F7136937" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1DFF152E394B171470CCDDD3F713B46E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_99D41D6E44302B6CA46CDDD3F7136937" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1DFF152E394B171470CCDDD3F713B46E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1DFF152E394B171470CCDDD3F713B46E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_99D41D6E44302B6CA46CDDD3F7136937" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1DFF152E394B171470CCDDD3F713B46E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_08AC187B133A30D051D5DDD3F714B590" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1DFF152E394B171470CCDDD3F713B46E" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_08AC187B133A30D051D5DDD3F714B590" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3CC8DE913AEA034517C5DDD3F7141DFF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8A8FD6D69EB17DA5A96ADDD3F713F546" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3CC8DE913AEA034517C5DDD3F7141DFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_37EC9D0121658F4AB1D8DDD3F714E74E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3CC8DE913AEA034517C5DDD3F7141DFF" xlink:to="loc_us-gaap_EquityComponentDomain_37EC9D0121658F4AB1D8DDD3F714E74E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_37EC9D0121658F4AB1D8DDD3F714E74E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3CC8DE913AEA034517C5DDD3F7141DFF" xlink:to="loc_us-gaap_EquityComponentDomain_37EC9D0121658F4AB1D8DDD3F714E74E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5C93F8F5A8ADE0DC5CD5DDD3F7149CE7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_37EC9D0121658F4AB1D8DDD3F714E74E" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5C93F8F5A8ADE0DC5CD5DDD3F7149CE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AociTaxAttributableToParent" xlink:label="loc_us-gaap_AociTaxAttributableToParent_83F26ACD085607375A0CDDD3F715D9E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_DD3D2EAE2F5FC80B263EDDD3F715E9F7" xlink:to="loc_us-gaap_AociTaxAttributableToParent_83F26ACD085607375A0CDDD3F715D9E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_6908DF1AAC63EEEEB85DDDD3F715FE5A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_DD3D2EAE2F5FC80B263EDDD3F715E9F7" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_6908DF1AAC63EEEEB85DDDD3F715FE5A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeSummaryOfAccumulatedBalancesRelatedToEachComponentOfOtherComprehensiveIncomeLossDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/BusinessOrganizationAndPresentation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/BusinessOrganizationAndPresentationDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesCftrActivatorsAndInhibitorsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesLineItems" xlink:label="loc_vnda_CommitmentsAndContingenciesLineItems_0297F9155B0142A46614434FF1DF7126" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesTable" xlink:label="loc_vnda_CommitmentsAndContingenciesTable_E2F27A97E5B20622EDF8434FF1DDE08D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_0297F9155B0142A46614434FF1DF7126" xlink:to="loc_vnda_CommitmentsAndContingenciesTable_E2F27A97E5B20622EDF8434FF1DDE08D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_BF8FFFF5B75DB0F511CF434FF1DD8953" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_E2F27A97E5B20622EDF8434FF1DDE08D" xlink:to="loc_srt_RangeAxis_BF8FFFF5B75DB0F511CF434FF1DD8953" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_AEE657D61601044A6B71434FF1DD641A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_BF8FFFF5B75DB0F511CF434FF1DD8953" xlink:to="loc_srt_RangeMember_AEE657D61601044A6B71434FF1DD641A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_AEE657D61601044A6B71434FF1DD641A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_BF8FFFF5B75DB0F511CF434FF1DD8953" xlink:to="loc_srt_RangeMember_AEE657D61601044A6B71434FF1DD641A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_916939F9D1550B7C0906434FF1DE5E52" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_AEE657D61601044A6B71434FF1DD641A" xlink:to="loc_srt_MaximumMember_916939F9D1550B7C0906434FF1DE5E52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98DEAF38DD76D081A0D2434FF1DE3E47" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_E2F27A97E5B20622EDF8434FF1DDE08D" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98DEAF38DD76D081A0D2434FF1DE3E47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98DEAF38DD76D081A0D2434FF1DE3E47" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98DEAF38DD76D081A0D2434FF1DE3E47" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_RegulatoryApprovalMilestoneMember" xlink:label="loc_vnda_RegulatoryApprovalMilestoneMember_ADDAAFC62E8881E7FB86434FF1DEC029" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E" xlink:to="loc_vnda_RegulatoryApprovalMilestoneMember_ADDAAFC62E8881E7FB86434FF1DEC029" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FutureRegulatoryApprovalAndSalesMilestonesMember" xlink:label="loc_vnda_FutureRegulatoryApprovalAndSalesMilestonesMember_5D80B4DF3A88336C177E434FF1DEF32A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E" xlink:to="loc_vnda_FutureRegulatoryApprovalAndSalesMilestonesMember_5D80B4DF3A88336C177E434FF1DEF32A" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_DevelopmentAndMilestonePaymentConclusionOfPhaseIStudyMember" xlink:label="loc_vnda_DevelopmentAndMilestonePaymentConclusionOfPhaseIStudyMember_D7C5048561B9139E9C06434FF1DF8005" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_E3652A03B0B52E4F4F8F434FF1DEB17E" xlink:to="loc_vnda_DevelopmentAndMilestonePaymentConclusionOfPhaseIStudyMember_D7C5048561B9139E9C06434FF1DF8005" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_847A7EDAC0271EFFA91A434FF1DFAF0D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_E2F27A97E5B20622EDF8434FF1DDE08D" xlink:to="loc_srt_ProductOrServiceAxis_847A7EDAC0271EFFA91A434FF1DFAF0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_A4A9EC4AE245B3AFFAF4434FF1DFF51B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_847A7EDAC0271EFFA91A434FF1DFAF0D" xlink:to="loc_srt_ProductsAndServicesDomain_A4A9EC4AE245B3AFFAF4434FF1DFF51B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_A4A9EC4AE245B3AFFAF4434FF1DFF51B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_847A7EDAC0271EFFA91A434FF1DFAF0D" xlink:to="loc_srt_ProductsAndServicesDomain_A4A9EC4AE245B3AFFAF4434FF1DFF51B" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CftrActivatorsAndInhibitorsMember" xlink:label="loc_vnda_CftrActivatorsAndInhibitorsMember_3E1F782E2BA8AD77EE28434FF1DFE95B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_A4A9EC4AE245B3AFFAF4434FF1DFF51B" xlink:to="loc_vnda_CftrActivatorsAndInhibitorsMember_3E1F782E2BA8AD77EE28434FF1DFE95B" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales" xlink:label="loc_vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales_8C59536A0206E12E2E97434FF1E0C248" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_0297F9155B0142A46614434FF1DF7126" xlink:to="loc_vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales_8C59536A0206E12E2E97434FF1E0C248" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CftrActivatorsAndInhibitorsAbstract" xlink:label="loc_vnda_CftrActivatorsAndInhibitorsAbstract_42AF953E2F5ADA0361EF434FF1E09E97" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_0297F9155B0142A46614434FF1DF7126" xlink:to="loc_vnda_CftrActivatorsAndInhibitorsAbstract_42AF953E2F5ADA0361EF434FF1E09E97" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_UpfrontLicenseFeeAndMilestonePaymentsMade" xlink:label="loc_vnda_UpfrontLicenseFeeAndMilestonePaymentsMade_AED1F7932E3AAB2CAFE6434FF1E0D481" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CftrActivatorsAndInhibitorsAbstract_42AF953E2F5ADA0361EF434FF1E09E97" xlink:to="loc_vnda_UpfrontLicenseFeeAndMilestonePaymentsMade_AED1F7932E3AAB2CAFE6434FF1E0D481" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty" xlink:label="loc_vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty_68D87173D50A43AD4EAC434FF1E02D43" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CftrActivatorsAndInhibitorsAbstract_42AF953E2F5ADA0361EF434FF1E09E97" xlink:to="loc_vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty_68D87173D50A43AD4EAC434FF1E02D43" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesFanaptAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesLineItems" xlink:label="loc_vnda_CommitmentsAndContingenciesLineItems_4F3E15E8896E8F4CBFEB434FC4C91B70" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesTable" xlink:label="loc_vnda_CommitmentsAndContingenciesTable_AB56B75CCB90B61DDC1F434FC4C513ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_4F3E15E8896E8F4CBFEB434FC4C91B70" xlink:to="loc_vnda_CommitmentsAndContingenciesTable_AB56B75CCB90B61DDC1F434FC4C513ED" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_32D88716ED0FB0ED3B7D434FC4C69C3E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_AB56B75CCB90B61DDC1F434FC4C513ED" xlink:to="loc_srt_ProductOrServiceAxis_32D88716ED0FB0ED3B7D434FC4C69C3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_001CFA772D6070969F70434FC4C66D0E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_32D88716ED0FB0ED3B7D434FC4C69C3E" xlink:to="loc_srt_ProductsAndServicesDomain_001CFA772D6070969F70434FC4C66D0E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_001CFA772D6070969F70434FC4C66D0E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_32D88716ED0FB0ED3B7D434FC4C69C3E" xlink:to="loc_srt_ProductsAndServicesDomain_001CFA772D6070969F70434FC4C66D0E" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FanaptMember" xlink:label="loc_vnda_FanaptMember_3001C9A8A733AFAEB350434FC4C77C69" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_001CFA772D6070969F70434FC4C66D0E" xlink:to="loc_vnda_FanaptMember_3001C9A8A733AFAEB350434FC4C77C69" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_StatementScenarioSecondaryAxis" xlink:label="loc_vnda_StatementScenarioSecondaryAxis_F9AB6D4E6E2BDF0ED6AF434FC4C73E9E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_AB56B75CCB90B61DDC1F434FC4C513ED" xlink:to="loc_vnda_StatementScenarioSecondaryAxis_F9AB6D4E6E2BDF0ED6AF434FC4C73E9E" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_StatementScenarioSecondaryDomain" xlink:label="loc_vnda_StatementScenarioSecondaryDomain_9BDB2A511CE263FB48DE434FC4C72A0F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_vnda_StatementScenarioSecondaryAxis_F9AB6D4E6E2BDF0ED6AF434FC4C73E9E" xlink:to="loc_vnda_StatementScenarioSecondaryDomain_9BDB2A511CE263FB48DE434FC4C72A0F_default" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_StatementScenarioSecondaryDomain" xlink:label="loc_vnda_StatementScenarioSecondaryDomain_9BDB2A511CE263FB48DE434FC4C72A0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_vnda_StatementScenarioSecondaryAxis_F9AB6D4E6E2BDF0ED6AF434FC4C73E9E" xlink:to="loc_vnda_StatementScenarioSecondaryDomain_9BDB2A511CE263FB48DE434FC4C72A0F" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ScenarioFourMember" xlink:label="loc_vnda_ScenarioFourMember_2AD519A614EB0AE5ECF3434FC4C85EC7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_StatementScenarioSecondaryDomain_9BDB2A511CE263FB48DE434FC4C72A0F" xlink:to="loc_vnda_ScenarioFourMember_2AD519A614EB0AE5ECF3434FC4C85EC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E83FBF39FF3A96AB04A8434FC4C8CAC3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_AB56B75CCB90B61DDC1F434FC4C513ED" xlink:to="loc_srt_RangeAxis_E83FBF39FF3A96AB04A8434FC4C8CAC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_FB54873DE41DEEA41F5C434FC4C96D6B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_E83FBF39FF3A96AB04A8434FC4C8CAC3" xlink:to="loc_srt_RangeMember_FB54873DE41DEEA41F5C434FC4C96D6B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_FB54873DE41DEEA41F5C434FC4C96D6B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_E83FBF39FF3A96AB04A8434FC4C8CAC3" xlink:to="loc_srt_RangeMember_FB54873DE41DEEA41F5C434FC4C96D6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_E490A2E6C45B856E8AA7434FC4C9F233" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_FB54873DE41DEEA41F5C434FC4C96D6B" xlink:to="loc_srt_MaximumMember_E490A2E6C45B856E8AA7434FC4C9F233" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FanaptAbstract" xlink:label="loc_vnda_FanaptAbstract_0536CDAFE92FF04344B1434FC4C97731" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_4F3E15E8896E8F4CBFEB434FC4C91B70" xlink:to="loc_vnda_FanaptAbstract_0536CDAFE92FF04344B1434FC4C97731" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_RoyaltyPayableOnNetSalesPercentage" xlink:label="loc_vnda_RoyaltyPayableOnNetSalesPercentage_E97112EF37718A4FA21B434FC4CA36E5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_FanaptAbstract_0536CDAFE92FF04344B1434FC4C97731" xlink:to="loc_vnda_RoyaltyPayableOnNetSalesPercentage_E97112EF37718A4FA21B434FC4CA36E5" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_RoyaltyPeriod" xlink:label="loc_vnda_RoyaltyPeriod_D3586B17245071F77A58434FC4CA6470" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_FanaptAbstract_0536CDAFE92FF04344B1434FC4C97731" xlink:to="loc_vnda_RoyaltyPeriod_D3586B17245071F77A58434FC4CA6470" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesHetliozAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesLineItems" xlink:label="loc_vnda_CommitmentsAndContingenciesLineItems_E804FD380E5321810E9CDDD3F7513DAE" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesTable" xlink:label="loc_vnda_CommitmentsAndContingenciesTable_37C1BA57A4756679F10ADDD3F75080B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_E804FD380E5321810E9CDDD3F7513DAE" xlink:to="loc_vnda_CommitmentsAndContingenciesTable_37C1BA57A4756679F10ADDD3F75080B6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_900573537A42284DA71FDDD3F75060D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_37C1BA57A4756679F10ADDD3F75080B6" xlink:to="loc_srt_ProductOrServiceAxis_900573537A42284DA71FDDD3F75060D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_0BBC2E52F3285D2C4EFBDDD3F751FDDE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_900573537A42284DA71FDDD3F75060D3" xlink:to="loc_srt_ProductsAndServicesDomain_0BBC2E52F3285D2C4EFBDDD3F751FDDE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_0BBC2E52F3285D2C4EFBDDD3F751FDDE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_900573537A42284DA71FDDD3F75060D3" xlink:to="loc_srt_ProductsAndServicesDomain_0BBC2E52F3285D2C4EFBDDD3F751FDDE" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_HetliozMember" xlink:label="loc_vnda_HetliozMember_D22CC1769EC5DDB16F46DDD3F75160BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0BBC2E52F3285D2C4EFBDDD3F751FDDE" xlink:to="loc_vnda_HetliozMember_D22CC1769EC5DDB16F46DDD3F75160BB" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_HetliozAbstract" xlink:label="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_E804FD380E5321810E9CDDD3F7513DAE" xlink:to="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_404A061EED9EB99ABD19DDD3F7520073" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_404A061EED9EB99ABD19DDD3F7520073" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CumulativeNetSalesToAchieveMilestone" xlink:label="loc_vnda_CumulativeNetSalesToAchieveMilestone_9962C5E4F70051C30357DDD3F752EDDA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:to="loc_vnda_CumulativeNetSalesToAchieveMilestone_9962C5E4F70051C30357DDD3F752EDDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_E82D1349DAEE85CD1E41DDD3F752B859" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_E82D1349DAEE85CD1E41DDD3F752B859" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_RoyaltyPayableOnNetSalesPercentage" xlink:label="loc_vnda_RoyaltyPayableOnNetSalesPercentage_12A6D3C68A28D2030003DDD3F75233B2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:to="loc_vnda_RoyaltyPayableOnNetSalesPercentage_12A6D3C68A28D2030003DDD3F75233B2" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_PercentageOfFutureSublicenseFeesPayable" xlink:label="loc_vnda_PercentageOfFutureSublicenseFeesPayable_6E6B1E8B2361EDD619D6DDD3F75282A5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:to="loc_vnda_PercentageOfFutureSublicenseFeesPayable_6E6B1E8B2361EDD619D6DDD3F75282A5" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_RoyaltyPeriod" xlink:label="loc_vnda_RoyaltyPeriod_D74D39E017468B9B4FCFDDD3F75332C1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_HetliozAbstract_7B208C662B0994176514DDD3F7512D08" xlink:to="loc_vnda_RoyaltyPeriod_D74D39E017468B9B4FCFDDD3F75332C1" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesResearchAndDevelopmentAndMarketingAgreementsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesSummaryOfNoncanellableLongTermContractualCashObligationsDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesTradipitantAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesLineItems" xlink:label="loc_vnda_CommitmentsAndContingenciesLineItems_DBD19F13E65EAC0823CA434FE04D6FB6" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesTable" xlink:label="loc_vnda_CommitmentsAndContingenciesTable_C6F5F35F5E4B5B7DE0C4434FE04947B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_DBD19F13E65EAC0823CA434FE04D6FB6" xlink:to="loc_vnda_CommitmentsAndContingenciesTable_C6F5F35F5E4B5B7DE0C4434FE04947B2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_C878F88ACFA9740B7738434FE049E863" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_C6F5F35F5E4B5B7DE0C4434FE04947B2" xlink:to="loc_srt_StatementGeographicalAxis_C878F88ACFA9740B7738434FE049E863" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_7A20AF70796ED7BFB990434FE0490A50_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_C878F88ACFA9740B7738434FE049E863" xlink:to="loc_srt_SegmentGeographicalDomain_7A20AF70796ED7BFB990434FE0490A50_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_7A20AF70796ED7BFB990434FE0490A50" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_C878F88ACFA9740B7738434FE049E863" xlink:to="loc_srt_SegmentGeographicalDomain_7A20AF70796ED7BFB990434FE0490A50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_FE3A6FC8DF4E344EA22E434FE04AF677" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7A20AF70796ED7BFB990434FE0490A50" xlink:to="loc_country_US_FE3A6FC8DF4E344EA22E434FE04AF677" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_EA90AA7FF4F2BC08F670434FE04A1460" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7A20AF70796ED7BFB990434FE0490A50" xlink:to="loc_srt_EuropeMember_EA90AA7FF4F2BC08F670434FE04A1460" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5392A4E4ACF9FF9C1E31434FE04AE755" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_C6F5F35F5E4B5B7DE0C4434FE04947B2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5392A4E4ACF9FF9C1E31434FE04AE755" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5D040CC2B1CB26C92E54434FE04A9C4F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5392A4E4ACF9FF9C1E31434FE04AE755" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5D040CC2B1CB26C92E54434FE04A9C4F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5D040CC2B1CB26C92E54434FE04A9C4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5392A4E4ACF9FF9C1E31434FE04AE755" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5D040CC2B1CB26C92E54434FE04A9C4F" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_TradipitantMember" xlink:label="loc_vnda_TradipitantMember_B72CFDE755C2F16A916E434FE04B4899" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5D040CC2B1CB26C92E54434FE04A9C4F" xlink:to="loc_vnda_TradipitantMember_B72CFDE755C2F16A916E434FE04B4899" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_748E6902626C72672B23434FE04B8E38" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_C6F5F35F5E4B5B7DE0C4434FE04947B2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_748E6902626C72672B23434FE04B8E38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_748E6902626C72672B23434FE04B8E38" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_748E6902626C72672B23434FE04B8E38" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_DevelopmentAndMilestonePaymentsOfPhaseThreeStudyPotentiallyDueToThirdPartyMember" xlink:label="loc_vnda_DevelopmentAndMilestonePaymentsOfPhaseThreeStudyPotentiallyDueToThirdPartyMember_B7B127C5F08EC5D57E00434FE04B238C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1" xlink:to="loc_vnda_DevelopmentAndMilestonePaymentsOfPhaseThreeStudyPotentiallyDueToThirdPartyMember_B7B127C5F08EC5D57E00434FE04B238C" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_RegulatoryApprovalMilestoneMember" xlink:label="loc_vnda_RegulatoryApprovalMilestoneMember_A3A397C8B88B2FC3E115434FE04C1EF2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1" xlink:to="loc_vnda_RegulatoryApprovalMilestoneMember_A3A397C8B88B2FC3E115434FE04C1EF2" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_SalesMilestoneMember" xlink:label="loc_vnda_SalesMilestoneMember_3AAE0CC87825C58C265F434FE04CA57A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_125DA4FEE117B9CD7840434FE04BB0E1" xlink:to="loc_vnda_SalesMilestoneMember_3AAE0CC87825C58C265F434FE04CA57A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_89B27729B4085019BFC1434FE04CF725" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_C6F5F35F5E4B5B7DE0C4434FE04947B2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_89B27729B4085019BFC1434FE04CF725" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B4AE8558D0EFE05EF18D434FE04C897C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89B27729B4085019BFC1434FE04CF725" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B4AE8558D0EFE05EF18D434FE04C897C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B4AE8558D0EFE05EF18D434FE04C897C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_89B27729B4085019BFC1434FE04CF725" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B4AE8558D0EFE05EF18D434FE04C897C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5DB4A1E991F21560F317434FE04DB922" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_B4AE8558D0EFE05EF18D434FE04C897C" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5DB4A1E991F21560F317434FE04DB922" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales" xlink:label="loc_vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales_5B25E64DFC76586F9242434FE04D375A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_DBD19F13E65EAC0823CA434FE04D6FB6" xlink:to="loc_vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales_5B25E64DFC76586F9242434FE04D375A" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty" xlink:label="loc_vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty_E446EF3F42DBF4DC0A55434FE04DB065" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_DBD19F13E65EAC0823CA434FE04D6FB6" xlink:to="loc_vnda_DevelopmentAndMilestonePaymentsPotentiallyDueToThirdParty_E446EF3F42DBF4DC0A55434FE04DB065" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_MilestoneObligationUnderLicenseAgreementCurrent" xlink:label="loc_vnda_MilestoneObligationUnderLicenseAgreementCurrent_0FBE881DE7A94ECC6885434FE04D293D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_DBD19F13E65EAC0823CA434FE04D6FB6" xlink:to="loc_vnda_MilestoneObligationUnderLicenseAgreementCurrent_0FBE881DE7A94ECC6885434FE04D293D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CommitmentsAndContingenciesVqw765AdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesLineItems" xlink:label="loc_vnda_CommitmentsAndContingenciesLineItems_9B5919DE0F6CC2A883ADDDB18662DAEF" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CommitmentsAndContingenciesTable" xlink:label="loc_vnda_CommitmentsAndContingenciesTable_660E9EEF3DB560658025DDB186608C76" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_9B5919DE0F6CC2A883ADDDB18662DAEF" xlink:to="loc_vnda_CommitmentsAndContingenciesTable_660E9EEF3DB560658025DDB186608C76" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1C35B45E88A239C54B10DDB186614B16" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_CommitmentsAndContingenciesTable_660E9EEF3DB560658025DDB186608C76" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1C35B45E88A239C54B10DDB186614B16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61F7DE8DD0CBB67091E9DDB186611C25_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1C35B45E88A239C54B10DDB186614B16" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61F7DE8DD0CBB67091E9DDB186611C25_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61F7DE8DD0CBB67091E9DDB186611C25" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1C35B45E88A239C54B10DDB186614B16" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61F7DE8DD0CBB67091E9DDB186611C25" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_VQW765Member" xlink:label="loc_vnda_VQW765Member_CD43EC84BA084EE82EB2DDB186612654" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_61F7DE8DD0CBB67091E9DDB186611C25" xlink:to="loc_vnda_VQW765Member_CD43EC84BA084EE82EB2DDB186612654" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales" xlink:label="loc_vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales_5FBFE23E5CD4EDE9DA54DDB1866200A3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_CommitmentsAndContingenciesLineItems_9B5919DE0F6CC2A883ADDDB18662DAEF" xlink:to="loc_vnda_FuturePercentageOfRoyaltyPaymentsBasedOnNetSales_5FBFE23E5CD4EDE9DA54DDB1866200A3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_AB76CC021AF23FA985663FB7DF0C1F63" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_207C0E6C325018A48FB03FB7DF0BB700" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_AB76CC021AF23FA985663FB7DF0C1F63" xlink:to="loc_us-gaap_StatementTable_207C0E6C325018A48FB03FB7DF0BB700" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_BD857BBEE88BFE8EFDF83FB7DF0B354D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_207C0E6C325018A48FB03FB7DF0BB700" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_BD857BBEE88BFE8EFDF83FB7DF0B354D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BD857BBEE88BFE8EFDF83FB7DF0B354D" xlink:to="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BD857BBEE88BFE8EFDF83FB7DF0B354D" xlink:to="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_B49996BCDCD0A70D3DAE3FB7DF0C4561" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A" xlink:to="loc_us-gaap_CommonStockMember_B49996BCDCD0A70D3DAE3FB7DF0C4561" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_066D200019103956CFB13FB7DF0C5DFC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_066D200019103956CFB13FB7DF0C5DFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0FFBADA2F8591B3A8B363FB7DF0C064D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0FFBADA2F8591B3A8B363FB7DF0C064D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_1C9D330BFD81FF691EB93FB7DF0CD269" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_E79613745597FAADF8023FB7DF0BE04A" xlink:to="loc_us-gaap_RetainedEarningsMember_1C9D330BFD81FF691EB93FB7DF0CD269" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_AB76CC021AF23FA985663FB7DF0C1F63" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_73BAA7B704D45C6DCCAE3FB7DF0D2E91" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_73BAA7B704D45C6DCCAE3FB7DF0D2E91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_2381EF1E40C998D178093FB7DF0DB62D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_StockholdersEquity_2381EF1E40C998D178093FB7DF0DB62D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_F880CC3D8B743A154CDE3FB7DF0D9FD4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_F880CC3D8B743A154CDE3FB7DF0D9FD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8808279C3412C5630D8F3FB7DF0D686D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8808279C3412C5630D8F3FB7DF0D686D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3D2FF584BFBFD94BFF5E3FB7DF0D6FF7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3D2FF584BFBFD94BFF5E3FB7DF0D6FF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8F71DD802066618A77073FB7DF0E5C24" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8F71DD802066618A77073FB7DF0E5C24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_33D1441A8A1F7DDA159E3FB7DF0E0F78" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_33D1441A8A1F7DDA159E3FB7DF0E0F78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_51074B42FD0ED1787F6F3FB7DF0E0AD6" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_NetIncomeLoss_51074B42FD0ED1787F6F3FB7DF0E0AD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_E3D542D5EB1A608B098D3FB7DF0E6F15" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9FF0C9C45F4B476275EF3FB7DF0CB1B6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_E3D542D5EB1A608B098D3FB7DF0E6F15" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/CoverPage" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/EarningsPerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/EarningsPerShareDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/FairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EA3482C0FA18A30F3DE6DDB1856366A8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E4D94DD0A6B62B2F2CE1DDB185610FEF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EA3482C0FA18A30F3DE6DDB1856366A8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E4D94DD0A6B62B2F2CE1DDB185610FEF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1951101643C0A22AF8EADDB185611BF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E4D94DD0A6B62B2F2CE1DDB185610FEF" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1951101643C0A22AF8EADDB185611BF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1951101643C0A22AF8EADDB185611BF1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1951101643C0A22AF8EADDB185611BF1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3328C30DB88F9C13CEDFDDB18562E25F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3328C30DB88F9C13CEDFDDB18562E25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_110BCE243E39E5F789BDDDB1856245E9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_110BCE243E39E5F789BDDDB1856245E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_AB777797D80C51D48A25DDB18562D504" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1EECBA79A6767EE00912DDB18561A464" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_AB777797D80C51D48A25DDB18562D504" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5C5A9ECA91A6FEA53783DDB18562D2CD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E4D94DD0A6B62B2F2CE1DDB185610FEF" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5C5A9ECA91A6FEA53783DDB18562D2CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5C5A9ECA91A6FEA53783DDB18562D2CD" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5C5A9ECA91A6FEA53783DDB18562D2CD" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_34CFA99353A0CCEB6D47DDB185632D7D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_34CFA99353A0CCEB6D47DDB185632D7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_61801CDCCBC5F2442E74DDB185630C45" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_61801CDCCBC5F2442E74DDB185630C45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_F77660944C1FBC09A8E6DDB1856367E5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_23FC98D7D021C81D52F6DDB18562F0F9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_F77660944C1FBC09A8E6DDB1856367E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ACEC55389EEA287E08D3DDB18563474D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_EA3482C0FA18A30F3DE6DDB1856366A8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ACEC55389EEA287E08D3DDB18563474D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsAdditionalInformationDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsFanaptAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_440B05E3C867607485E7DDB18605B7F4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_16EAE3A450F48A3F1A3DDDB1860468DB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_440B05E3C867607485E7DDB18605B7F4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_16EAE3A450F48A3F1A3DDDB1860468DB" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_10C6641ABB095E6B74B6DDB1860571DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_16EAE3A450F48A3F1A3DDDB1860468DB" xlink:to="loc_srt_ProductOrServiceAxis_10C6641ABB095E6B74B6DDB1860571DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_0CD125CA1291BA2CBBE6DDB186056B04_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_10C6641ABB095E6B74B6DDB1860571DC" xlink:to="loc_srt_ProductsAndServicesDomain_0CD125CA1291BA2CBBE6DDB186056B04_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_0CD125CA1291BA2CBBE6DDB186056B04" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_10C6641ABB095E6B74B6DDB1860571DC" xlink:to="loc_srt_ProductsAndServicesDomain_0CD125CA1291BA2CBBE6DDB186056B04" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FanaptMember" xlink:label="loc_vnda_FanaptMember_807BD52C6982EDFB3141DDB186056476" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0CD125CA1291BA2CBBE6DDB186056B04" xlink:to="loc_vnda_FanaptMember_807BD52C6982EDFB3141DDB186056476" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_407E17CBE81FAE251198DDB18606186D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_440B05E3C867607485E7DDB18605B7F4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_407E17CBE81FAE251198DDB18606186D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsHetliozAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_F4307192B2A3FA562558DDB18667B958" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_256AD884B29F595B399FDDB186664DD0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_F4307192B2A3FA562558DDB18667B958" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_256AD884B29F595B399FDDB186664DD0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_88286A1D067AB34FE8FEDDB186666742" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_256AD884B29F595B399FDDB186664DD0" xlink:to="loc_srt_ProductOrServiceAxis_88286A1D067AB34FE8FEDDB186666742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_EEC1818BED85A13CF631DDB18666A275_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_88286A1D067AB34FE8FEDDB186666742" xlink:to="loc_srt_ProductsAndServicesDomain_EEC1818BED85A13CF631DDB18666A275_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_EEC1818BED85A13CF631DDB18666A275" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_88286A1D067AB34FE8FEDDB186666742" xlink:to="loc_srt_ProductsAndServicesDomain_EEC1818BED85A13CF631DDB18666A275" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_HetliozMember" xlink:label="loc_vnda_HetliozMember_BE47FE3FF218A8EF7BA8DDB186679B43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_EEC1818BED85A13CF631DDB18666A275" xlink:to="loc_vnda_HetliozMember_BE47FE3FF218A8EF7BA8DDB186679B43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3AD76E7A593C6E160672DDB18667B45C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_F4307192B2A3FA562558DDB18667B958" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3AD76E7A593C6E160672DDB18667B45C" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CumulativeNetSalesToAchieveMilestone" xlink:label="loc_vnda_CumulativeNetSalesToAchieveMilestone_66EE71F817D5667D1B51DDB18668D092" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_F4307192B2A3FA562558DDB18667B958" xlink:to="loc_vnda_CumulativeNetSalesToAchieveMilestone_66EE71F817D5667D1B51DDB18668D092" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_MilestoneObligationUnderLicenseAgreementCurrent" xlink:label="loc_vnda_MilestoneObligationUnderLicenseAgreementCurrent_CDDA2120C0EE266AFA0EDDB18668CC5D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_F4307192B2A3FA562558DDB18667B958" xlink:to="loc_vnda_MilestoneObligationUnderLicenseAgreementCurrent_CDDA2120C0EE266AFA0EDDB18668CC5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_B64958D38AF2D268EB6FDDB18668CFF3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_F4307192B2A3FA562558DDB18667B958" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_B64958D38AF2D268EB6FDDB18668CFF3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsSummaryOfFutureIntangibleAssetAmortizationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0B991F68BFFDD530D806DDB186237BE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0B991F68BFFDD530D806DDB186237BE0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_9C0222C4D81984F24C24DDB18623A404" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0B991F68BFFDD530D806DDB186237BE0" xlink:to="loc_srt_ProductOrServiceAxis_9C0222C4D81984F24C24DDB18623A404" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_0459A6A4B6DB5E489CDDDDB1862359CA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9C0222C4D81984F24C24DDB18623A404" xlink:to="loc_srt_ProductsAndServicesDomain_0459A6A4B6DB5E489CDDDDB1862359CA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_0459A6A4B6DB5E489CDDDDB1862359CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9C0222C4D81984F24C24DDB18623A404" xlink:to="loc_srt_ProductsAndServicesDomain_0459A6A4B6DB5E489CDDDDB1862359CA" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_HetliozMember" xlink:label="loc_vnda_HetliozMember_87F486B604B44371001CDDB18623706E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0459A6A4B6DB5E489CDDDDB1862359CA" xlink:to="loc_vnda_HetliozMember_87F486B604B44371001CDDB18623706E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7BA62B2DD8E5DD92F340DDB1862489BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7BA62B2DD8E5DD92F340DDB1862489BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7379C60C88266E20E713DDB186241721" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_7379C60C88266E20E713DDB186241721" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1E254E39C135089D0924DDB18624B5F1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1E254E39C135089D0924DDB18624B5F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_550EAA45D67BA112E629DDB1862582D0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_550EAA45D67BA112E629DDB1862582D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6D5680C3EECD5C4E2D85DDB186252E0E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6D5680C3EECD5C4E2D85DDB186252E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5A8033139FD2897C7250DDB1862589D0" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5A8033139FD2897C7250DDB1862589D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_D09E05C4581DA2B681D3DDB18625F870" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_02668DA4C0EDE92C59F1DDB18624B70B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_D09E05C4581DA2B681D3DDB18625F870" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsSummaryOfIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_62D658D281760799C640DDB18681FD6E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DA5F3AD4D84EBACCFE65DDB186808B87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_62D658D281760799C640DDB18681FD6E" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DA5F3AD4D84EBACCFE65DDB186808B87" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_EB42A5DC7A837B41819DDDB18680A92B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DA5F3AD4D84EBACCFE65DDB186808B87" xlink:to="loc_srt_ProductOrServiceAxis_EB42A5DC7A837B41819DDDB18680A92B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_FD11E25BA0F3DE74B622DDB1868099DC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_EB42A5DC7A837B41819DDDB18680A92B" xlink:to="loc_srt_ProductsAndServicesDomain_FD11E25BA0F3DE74B622DDB1868099DC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_FD11E25BA0F3DE74B622DDB1868099DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_EB42A5DC7A837B41819DDDB18680A92B" xlink:to="loc_srt_ProductsAndServicesDomain_FD11E25BA0F3DE74B622DDB1868099DC" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_HetliozMember" xlink:label="loc_vnda_HetliozMember_F8E945DAF257B6F99586DDB1868192E7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_FD11E25BA0F3DE74B622DDB1868099DC" xlink:to="loc_vnda_HetliozMember_F8E945DAF257B6F99586DDB1868192E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2B4DD73398CA7354B2BBDDB186812BA9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_62D658D281760799C640DDB18681FD6E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2B4DD73398CA7354B2BBDDB186812BA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7802DE1C5698DA15FE75DDB1868107F2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_62D658D281760799C640DDB18681FD6E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7802DE1C5698DA15FE75DDB1868107F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9BBCCA847A1C960C164EDDB186824EC7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_62D658D281760799C640DDB18681FD6E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9BBCCA847A1C960C164EDDB186824EC7" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/Inventory" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/InventoryDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/InventoryTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8000AE0B87AE688E5ABD43243B3666B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8000AE0B87AE688E5ABD43243B3666B0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_60F3AB56BFE827663A4043243B362714" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8000AE0B87AE688E5ABD43243B3666B0" xlink:to="loc_us-gaap_TypeOfArrangementAxis_60F3AB56BFE827663A4043243B362714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_D0489029853320028B9B43243B3603C0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_60F3AB56BFE827663A4043243B362714" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_D0489029853320028B9B43243B3603C0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_D0489029853320028B9B43243B3603C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_60F3AB56BFE827663A4043243B362714" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_D0489029853320028B9B43243B3603C0" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_SubleaseMember" xlink:label="loc_vnda_SubleaseMember_274BB45D2DC90202F5F043243B37B845" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_D0489029853320028B9B43243B3603C0" xlink:to="loc_vnda_SubleaseMember_274BB45D2DC90202F5F043243B37B845" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis_775F928A9DF340589F8D43243B379EB6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8000AE0B87AE688E5ABD43243B3666B0" xlink:to="loc_us-gaap_LeaseArrangementTypeAxis_775F928A9DF340589F8D43243B379EB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_14787F1BABC56230576543243B370367_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_775F928A9DF340589F8D43243B379EB6" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_14787F1BABC56230576543243B370367_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_14787F1BABC56230576543243B370367" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_775F928A9DF340589F8D43243B379EB6" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_14787F1BABC56230576543243B370367" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_WashingtonDcLeaseMember" xlink:label="loc_vnda_WashingtonDcLeaseMember_98B4BB5B41899499A28D43243B37EFB7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_14787F1BABC56230576543243B370367" xlink:to="loc_vnda_WashingtonDcLeaseMember_98B4BB5B41899499A28D43243B37EFB7" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_LondonLeaseMember" xlink:label="loc_vnda_LondonLeaseMember_AB55DB53D95075F78A1543243B389823" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_14787F1BABC56230576543243B370367" xlink:to="loc_vnda_LondonLeaseMember_AB55DB53D95075F78A1543243B389823" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_21F2C3C4201C60464CA143243B38677C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_21F2C3C4201C60464CA143243B38677C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_DED5D0A6D129369EEE8043243B39A0AE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_DED5D0A6D129369EEE8043243B39A0AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_007BB4888E071C7DDF2543243B39BAD1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_OperatingLeaseCost_007BB4888E071C7DDF2543243B39BAD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_1063BC68BECBA1F2C96F43243B393077" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_ShortTermLeaseCost_1063BC68BECBA1F2C96F43243B393077" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_OperatingLeaseNonLeaseComponentExpense" xlink:label="loc_vnda_OperatingLeaseNonLeaseComponentExpense_A82FBF89A17B61AF4A1243243B39854F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_vnda_OperatingLeaseNonLeaseComponentExpense_A82FBF89A17B61AF4A1243243B39854F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_E132A5ECE8B22BB02B2843243B394327" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_LeaseAndRentalExpense_E132A5ECE8B22BB02B2843243B394327" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_7A1AB375A57A6A58756543243B39C046" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_88721DECA5B192CAF6F343243B381714" xlink:to="loc_us-gaap_OperatingLeasePayments_7A1AB375A57A6A58756543243B39C046" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/LeasesLeaseAssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/LeasesMaturitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/LeasesMaturitiesUnderAsc840Details" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/LegalMatters" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/MarketableSecurities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/MarketableSecuritiesAvailableForSaleMarketableSecuritiesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09B6C5237DF384B97FC0460CBD9C36AE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_72DAAF0F9E9B2C54292E460CBD9708BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09B6C5237DF384B97FC0460CBD9C36AE" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_72DAAF0F9E9B2C54292E460CBD9708BD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_20F54A8851D44B17E583460CBD97D41E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_72DAAF0F9E9B2C54292E460CBD9708BD" xlink:to="loc_us-gaap_InvestmentTypeAxis_20F54A8851D44B17E583460CBD97D41E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_FC9FF2FFEC97BBFFDC67460CBD971E29_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_20F54A8851D44B17E583460CBD97D41E" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_FC9FF2FFEC97BBFFDC67460CBD971E29_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_FC9FF2FFEC97BBFFDC67460CBD971E29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_20F54A8851D44B17E583460CBD97D41E" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_FC9FF2FFEC97BBFFDC67460CBD971E29" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_CurrentInvestmentMember" xlink:label="loc_vnda_CurrentInvestmentMember_FAD29557E528EF1A8879460CBD98C495" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_FC9FF2FFEC97BBFFDC67460CBD971E29" xlink:to="loc_vnda_CurrentInvestmentMember_FAD29557E528EF1A8879460CBD98C495" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_NoncurrentInvestmentsMember" xlink:label="loc_vnda_NoncurrentInvestmentsMember_9E664A9EB3D49D3F7AD6460CBD98F8B2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_FC9FF2FFEC97BBFFDC67460CBD971E29" xlink:to="loc_vnda_NoncurrentInvestmentsMember_9E664A9EB3D49D3F7AD6460CBD98F8B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66178E9717C2F38BD8C5460CBD98AA2D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_72DAAF0F9E9B2C54292E460CBD9708BD" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66178E9717C2F38BD8C5460CBD98AA2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66178E9717C2F38BD8C5460CBD98AA2D" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66178E9717C2F38BD8C5460CBD98AA2D" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_FBA8844F03038D6D950F460CBD993F5C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_FBA8844F03038D6D950F460CBD993F5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_F07C9F6D443B242BDDBB460CBD9C3CDA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_F07C9F6D443B242BDDBB460CBD9C3CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_99962DA907F3A868BD49460CBD9CE822" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0152EFFBE93842756F22460CBD98C941" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_99962DA907F3A868BD49460CBD9CE822" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C3B9701C19501A86F6B9460CBD9C5098" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09B6C5237DF384B97FC0460CBD9C36AE" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_C3B9701C19501A86F6B9460CBD9C5098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7323715F706632E1A1C2460CBD9D539F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09B6C5237DF384B97FC0460CBD9C36AE" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7323715F706632E1A1C2460CBD9D539F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_01103A98E07989A3DCDE460CBD9D753A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09B6C5237DF384B97FC0460CBD9C36AE" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_01103A98E07989A3DCDE460CBD9D753A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_D2526DEC4CBBB2DE11BF460CBD9DB814" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09B6C5237DF384B97FC0460CBD9C36AE" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_D2526DEC4CBBB2DE11BF460CBD9DB814" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/MarketableSecuritiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/PublicOfferingOfCommonStock" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/PublicOfferingOfCommonStockDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_BE8C2702CFF2A8870C6BDDB186799D80" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_C0CF9D06283D0BE47CDBDDB1867869AC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_BE8C2702CFF2A8870C6BDDB186799D80" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_C0CF9D06283D0BE47CDBDDB1867869AC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7128C25A991D163B921EDDB18678F923" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_C0CF9D06283D0BE47CDBDDB1867869AC" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7128C25A991D163B921EDDB18678F923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1F8DBF7D79AA6D649F35DDB186785A87_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7128C25A991D163B921EDDB18678F923" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1F8DBF7D79AA6D649F35DDB186785A87_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1F8DBF7D79AA6D649F35DDB186785A87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7128C25A991D163B921EDDB18678F923" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1F8DBF7D79AA6D649F35DDB186785A87" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_PublicOfferingMember" xlink:label="loc_vnda_PublicOfferingMember_D52167CCB3EF28766D56DDB18678E09E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1F8DBF7D79AA6D649F35DDB186785A87" xlink:to="loc_vnda_PublicOfferingMember_D52167CCB3EF28766D56DDB18678E09E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_146E05A044562A37613EDDB186794038" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1F8DBF7D79AA6D649F35DDB186785A87" xlink:to="loc_us-gaap_OverAllotmentOptionMember_146E05A044562A37613EDDB186794038" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_DCFCA3D4F4CF75A3E010DDB18679EB61" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_BE8C2702CFF2A8870C6BDDB186799D80" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_DCFCA3D4F4CF75A3E010DDB18679EB61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_49DD90F903C830DC354DDDB1867A670D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_BE8C2702CFF2A8870C6BDDB186799D80" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_49DD90F903C830DC354DDDB1867A670D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_D3325092AB673215A669DDB1867A030C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_BE8C2702CFF2A8870C6BDDB186799D80" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_D3325092AB673215A669DDB1867A030C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationBlackScholesMertonOptionPricingModelForStockOptionsGrantedDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationRsuAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B0C0279305CB7A3E7202DDB186B0E86A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B0C0279305CB7A3E7202DDB186B0E86A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9920DB28C9DF6E29B4B1DDB186B108BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B0C0279305CB7A3E7202DDB186B0E86A" xlink:to="loc_us-gaap_AwardTypeAxis_9920DB28C9DF6E29B4B1DDB186B108BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67C1C73D51FAEFAB3D30DDB186B152E9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9920DB28C9DF6E29B4B1DDB186B108BC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67C1C73D51FAEFAB3D30DDB186B152E9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67C1C73D51FAEFAB3D30DDB186B152E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9920DB28C9DF6E29B4B1DDB186B108BC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67C1C73D51FAEFAB3D30DDB186B152E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_A50FF6C4446CE4D69313DDB186B14FBE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67C1C73D51FAEFAB3D30DDB186B152E9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_A50FF6C4446CE4D69313DDB186B14FBE" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodOne" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodOne_278D3C4F9C9750B40E9BDDB186B22C98" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodOne_278D3C4F9C9750B40E9BDDB186B22C98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_BE783C15473F1ABAE707DDB186B2FA9D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_BE783C15473F1ABAE707DDB186B2FA9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6EBF1308D2897DE1642CDDB186B2489E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6EBF1308D2897DE1642CDDB186B2489E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0421D4913B6DB9787E75DDB186B21888" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0421D4913B6DB9787E75DDB186B21888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7FCE5766D07B6D7D3C97DDB186B2D4D2" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B029D0BAA4ED4578C6EADDB186B14A3C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7FCE5766D07B6D7D3C97DDB186B2D4D2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationStockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DD0E4B2055CEB0C23971DDB1861D4B30" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C01879CC4B78B6F0E6A9DDB1861AB7D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DD0E4B2055CEB0C23971DDB1861D4B30" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C01879CC4B78B6F0E6A9DDB1861AB7D0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_44820D4A8A8D801B07A7DDB1861BC7D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C01879CC4B78B6F0E6A9DDB1861AB7D0" xlink:to="loc_us-gaap_PlanNameAxis_44820D4A8A8D801B07A7DDB1861BC7D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_36721E7645BBE1AA5ADEDDB1861B412D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_44820D4A8A8D801B07A7DDB1861BC7D4" xlink:to="loc_us-gaap_PlanNameDomain_36721E7645BBE1AA5ADEDDB1861B412D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_36721E7645BBE1AA5ADEDDB1861B412D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_44820D4A8A8D801B07A7DDB1861BC7D4" xlink:to="loc_us-gaap_PlanNameDomain_36721E7645BBE1AA5ADEDDB1861B412D" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_TwoThousandSixPlanAndTwoThousandSixteenPlanMember" xlink:label="loc_vnda_TwoThousandSixPlanAndTwoThousandSixteenPlanMember_BD54EAE12587C4BE0317DDB1861C9FBB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_36721E7645BBE1AA5ADEDDB1861B412D" xlink:to="loc_vnda_TwoThousandSixPlanAndTwoThousandSixteenPlanMember_BD54EAE12587C4BE0317DDB1861C9FBB" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_TwoThousandSixteenPlanMember" xlink:label="loc_vnda_TwoThousandSixteenPlanMember_8467BDE245409DF8E3ABDDB1861C897E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_36721E7645BBE1AA5ADEDDB1861B412D" xlink:to="loc_vnda_TwoThousandSixteenPlanMember_8467BDE245409DF8E3ABDDB1861C897E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_8263C8EFDD83E10E0B7DDDB1861CB070" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C01879CC4B78B6F0E6A9DDB1861AB7D0" xlink:to="loc_us-gaap_AwardTypeAxis_8263C8EFDD83E10E0B7DDDB1861CB070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50C1681501C5E6238211DDB1861C8C4F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8263C8EFDD83E10E0B7DDDB1861CB070" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50C1681501C5E6238211DDB1861C8C4F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50C1681501C5E6238211DDB1861C8C4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8263C8EFDD83E10E0B7DDDB1861CB070" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50C1681501C5E6238211DDB1861C8C4F" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_StockOptionsAndRestrictedStockUnitsRSUsMember" xlink:label="loc_vnda_StockOptionsAndRestrictedStockUnitsRSUsMember_40F6CCFA2A6BAAA1EE57DDB1861C096D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50C1681501C5E6238211DDB1861C8C4F" xlink:to="loc_vnda_StockOptionsAndRestrictedStockUnitsRSUsMember_40F6CCFA2A6BAAA1EE57DDB1861C096D" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsRSUOutstandingNumber" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsRSUOutstandingNumber_3694D9094E390DCE386CDDB1861DB537" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DD0E4B2055CEB0C23971DDB1861D4B30" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsRSUOutstandingNumber_3694D9094E390DCE386CDDB1861DB537" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_703AC09CBCC7FE464704DDB1861DE8E1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DD0E4B2055CEB0C23971DDB1861D4B30" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_703AC09CBCC7FE464704DDB1861DE8E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C024AD6A0151CEB6C11DDB1861D8E54" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_DD0E4B2055CEB0C23971DDB1861D4B30" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6C024AD6A0151CEB6C11DDB1861D8E54" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationStockOptionAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C5B25ED1F4A4FFBB5313DDB185F9C987" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C5B25ED1F4A4FFBB5313DDB185F9C987" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5274AF2C91E426E84CBCDDB185FA7C05" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C5B25ED1F4A4FFBB5313DDB185F9C987" xlink:to="loc_us-gaap_AwardTypeAxis_5274AF2C91E426E84CBCDDB185FA7C05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A236D193BA2232607C0DDDB185FA5F1D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5274AF2C91E426E84CBCDDB185FA7C05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A236D193BA2232607C0DDDB185FA5F1D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A236D193BA2232607C0DDDB185FA5F1D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5274AF2C91E426E84CBCDDB185FA7C05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A236D193BA2232607C0DDDB185FA5F1D" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ServiceOptionAwardsMember" xlink:label="loc_vnda_ServiceOptionAwardsMember_CD57D18C9FB6E8038BC9DDB185FABF47" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A236D193BA2232607C0DDDB185FA5F1D" xlink:to="loc_vnda_ServiceOptionAwardsMember_CD57D18C9FB6E8038BC9DDB185FABF47" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationOptionAwardsContractualTerm" xlink:label="loc_vnda_ShareBasedCompensationOptionAwardsContractualTerm_79430D440CADF59D9ACFDDB185FBF084" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_vnda_ShareBasedCompensationOptionAwardsContractualTerm_79430D440CADF59D9ACFDDB185FBF084" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShareSubjectToOptionAwards" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShareSubjectToOptionAwards_4CDBAD6A0D0CC71457ADDDB185FB586E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShareSubjectToOptionAwards_4CDBAD6A0D0CC71457ADDDB185FB586E" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingPercentageOfShareSubjectToOptionAwards" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingPercentageOfShareSubjectToOptionAwards_CAB1F5FF05843EF88BF7DDB185FB6A91" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingPercentageOfShareSubjectToOptionAwards_CAB1F5FF05843EF88BF7DDB185FB6A91" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_OptionAwardsVestingPeriodAfterCompletionOfOneYearOfService" xlink:label="loc_vnda_OptionAwardsVestingPeriodAfterCompletionOfOneYearOfService_138EF6C6564057ED3910DDB185FB3E55" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_vnda_OptionAwardsVestingPeriodAfterCompletionOfOneYearOfService_138EF6C6564057ED3910DDB185FB3E55" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAnnualAwardVestingPeriodDirectors" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAnnualAwardVestingPeriodDirectors_4CCA10D7EBC146614371DDB185FC6ED6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAnnualAwardVestingPeriodDirectors_4CCA10D7EBC146614371DDB185FC6ED6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9BB33AC99ACEE376B7E5DDB185FC510F" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9BB33AC99ACEE376B7E5DDB185FC510F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_648A215379BBA1400D5BDDB185FC447E" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_648A215379BBA1400D5BDDB185FC447E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_82A6119A7B2B32968C77DDB185FCFF8B" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_82A6119A7B2B32968C77DDB185FCFF8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_08D77BCB3EA6E29BE9C6DDB185FD822E" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E88CA13DF2D1CB75488DDB185FBF454" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_08D77BCB3EA6E29BE9C6DDB185FD822E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationSummaryOfOptionActivityFor2006PlanAnd2016PlanDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4AD33550745B2D87D639DDB186C06E45" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4AD33550745B2D87D639DDB186C06E45" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_33C1EB864F309B86C650DDB186C07869" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4AD33550745B2D87D639DDB186C06E45" xlink:to="loc_us-gaap_PlanNameAxis_33C1EB864F309B86C650DDB186C07869" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_E920266222E953E657E1DDB186C041C2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_33C1EB864F309B86C650DDB186C07869" xlink:to="loc_us-gaap_PlanNameDomain_E920266222E953E657E1DDB186C041C2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_E920266222E953E657E1DDB186C041C2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_33C1EB864F309B86C650DDB186C07869" xlink:to="loc_us-gaap_PlanNameDomain_E920266222E953E657E1DDB186C041C2" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_TwoThousandSixPlanAndTwoThousandSixteenPlanMember" xlink:label="loc_vnda_TwoThousandSixPlanAndTwoThousandSixteenPlanMember_5DD4C86B620067A0EAB4DDB186C04091" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_E920266222E953E657E1DDB186C041C2" xlink:to="loc_vnda_TwoThousandSixPlanAndTwoThousandSixteenPlanMember_5DD4C86B620067A0EAB4DDB186C04091" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5A0C2B3DF27F02AAA76BDDB186C1D0B5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5A0C2B3DF27F02AAA76BDDB186C1D0B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B27632E675AA59E6A998DDB186C10A1D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5A0C2B3DF27F02AAA76BDDB186C1D0B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B27632E675AA59E6A998DDB186C10A1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_359D2C3D9FB89F357C29DDB186C2DB75" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5A0C2B3DF27F02AAA76BDDB186C1D0B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_359D2C3D9FB89F357C29DDB186C2DB75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_81AB4A9CB1AC2F9CF304DDB186C2F199" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5A0C2B3DF27F02AAA76BDDB186C1D0B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_81AB4A9CB1AC2F9CF304DDB186C2F199" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_09F4C4DD8E0C764E9AECDDB186C2F7E0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5A0C2B3DF27F02AAA76BDDB186C1D0B5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_09F4C4DD8E0C764E9AECDDB186C2F7E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_581060CF52B1E4E9A946DDB186C25483" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_581060CF52B1E4E9A946DDB186C25483" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2299A69D3B72AB8ADD8FDDB186C20D10" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2299A69D3B72AB8ADD8FDDB186C20D10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_43348F6FF2C82414AF43DDB186C3CDE4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_43348F6FF2C82414AF43DDB186C3CDE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_842BBE30CE02B4227D59DDB186C36374" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_842BBE30CE02B4227D59DDB186C36374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_04F2179533F9E934C32EDDB186C3CA6B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_04F2179533F9E934C32EDDB186C3CA6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3D9802414B8747E17076DDB186C32783" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3D9802414B8747E17076DDB186C32783" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ECD5AE339C67050A54DDDDB186C4891E" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ECD5AE339C67050A54DDDDB186C4891E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2E9CE0A4543D95CED53EDDB186C4EF95" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4F3E6E0ACAA30B647B73DDB186C3497F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2E9CE0A4543D95CED53EDDB186C4EF95" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_130E3FCE965C05C3275FDDB186C465EB" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_130E3FCE965C05C3275FDDB186C465EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8F009A374F66511567F6DDB186C4714A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_130E3FCE965C05C3275FDDB186C465EB" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8F009A374F66511567F6DDB186C4714A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1834448E2272FD5B26ABDDB186C51EB9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_130E3FCE965C05C3275FDDB186C465EB" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1834448E2272FD5B26ABDDB186C51EB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3A5A3457E2D308284403DDB186C5ED66" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_130E3FCE965C05C3275FDDB186C465EB" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3A5A3457E2D308284403DDB186C5ED66" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_F908D3AE7ABA93E00DFBDDB186C5DD72" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72ADCFB4258C1488CC28DDB186C15545" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_F908D3AE7ABA93E00DFBDDB186C5DD72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_152B59B8B32F793DE574DDB186C5F8BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_F908D3AE7ABA93E00DFBDDB186C5DD72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_152B59B8B32F793DE574DDB186C5F8BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ACEE965DAB034E17A02CDDB186C5E17F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_F908D3AE7ABA93E00DFBDDB186C5DD72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ACEE965DAB034E17A02CDDB186C5E17F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_13C896115A606D93252CDDB186C6A431" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_F908D3AE7ABA93E00DFBDDB186C5DD72" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_13C896115A606D93252CDDB186C6A431" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_CFC88D6A8B971D1693CDDDB186C68791" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_F908D3AE7ABA93E00DFBDDB186C5DD72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_CFC88D6A8B971D1693CDDDB186C68791" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationSummaryOfRsuActivityPlanDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsLineItems" xlink:label="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsLineItems_2A1C79A7E1E436EBEBC6DDB18671C509" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsTable" xlink:label="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsTable_B9EAE030FC1B71514E8BDDB18670D37B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsLineItems_2A1C79A7E1E436EBEBC6DDB18671C509" xlink:to="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsTable_B9EAE030FC1B71514E8BDDB18670D37B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_86D8D2F821797FED02C3DDB186703231" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsTable_B9EAE030FC1B71514E8BDDB18670D37B" xlink:to="loc_us-gaap_AwardTypeAxis_86D8D2F821797FED02C3DDB186703231" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14BBA181CBA293B589AADDB186714E8E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_86D8D2F821797FED02C3DDB186703231" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14BBA181CBA293B589AADDB186714E8E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14BBA181CBA293B589AADDB186714E8E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_86D8D2F821797FED02C3DDB186703231" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14BBA181CBA293B589AADDB186714E8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_CCE88AE826C5765773B0DDB186711010" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14BBA181CBA293B589AADDB186714E8E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_CCE88AE826C5765773B0DDB186711010" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86C2448A06B2F426D5FDDDB1867135B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsLineItems_2A1C79A7E1E436EBEBC6DDB18671C509" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86C2448A06B2F426D5FDDDB1867135B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_232795561FA4B0C01FA5DDB186721C38" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86C2448A06B2F426D5FDDDB1867135B8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_232795561FA4B0C01FA5DDB186721C38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8A399906F71E5F926777DDB18672A7F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86C2448A06B2F426D5FDDDB1867135B8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8A399906F71E5F926777DDB18672A7F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_B2ACBAE88CA42621A0B9DDB18672A6E4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86C2448A06B2F426D5FDDDB1867135B8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_B2ACBAE88CA42621A0B9DDB18672A6E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7FFDBCD59DAF18CF7B5BDDB18672CA9E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_86C2448A06B2F426D5FDDDB1867135B8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7FFDBCD59DAF18CF7B5BDDB18672CA9E" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract_A5C1B21E2EDF9949D170DDB18673A1F1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsLineItems_2A1C79A7E1E436EBEBC6DDB18671C509" xlink:to="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract_A5C1B21E2EDF9949D170DDB18673A1F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0535F50468DC5645FD5ADDB18673E9EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract_A5C1B21E2EDF9949D170DDB18673A1F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0535F50468DC5645FD5ADDB18673E9EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_545E68F310E4F2AF0186DDB18673D9AF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract_A5C1B21E2EDF9949D170DDB18673A1F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_545E68F310E4F2AF0186DDB18673D9AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_F7515236CC01635AF732DDB18673F8E0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract_A5C1B21E2EDF9949D170DDB18673A1F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_F7515236CC01635AF732DDB18673F8E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_68CBB24CD6D903A4ED37DDB18674A8AB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValueAbstract_A5C1B21E2EDF9949D170DDB18673A1F1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_68CBB24CD6D903A4ED37DDB18674A8AB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/StockBasedCompensationTotalStockBasedCompensationExpenseDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_BDF8254E7B05E9823A9EDDB185F20A98" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D747687C625C3935D1E7DDB185F16F40" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_BDF8254E7B05E9823A9EDDB185F20A98" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D747687C625C3935D1E7DDB185F16F40" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_B8F8C921FD130305752ADDB185F140D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D747687C625C3935D1E7DDB185F16F40" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_B8F8C921FD130305752ADDB185F140D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_83154CA09451B8E97FC1DDB185F29DE5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_B8F8C921FD130305752ADDB185F140D7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_83154CA09451B8E97FC1DDB185F29DE5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_83154CA09451B8E97FC1DDB185F29DE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_B8F8C921FD130305752ADDB185F140D7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_83154CA09451B8E97FC1DDB185F29DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_A6266F084F40613AC710DDB185F29F26" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_83154CA09451B8E97FC1DDB185F29DE5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_A6266F084F40613AC710DDB185F29F26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_67B886D1B5C6B4C308C7DDB185F27EB3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_83154CA09451B8E97FC1DDB185F29DE5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_67B886D1B5C6B4C308C7DDB185F27EB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_31551BE57D451BD74F05DDB185F2847D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_BDF8254E7B05E9823A9EDDB185F20A98" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_31551BE57D451BD74F05DDB185F2847D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="vnda-20190630.xsd#vnda_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_vnda_SummaryOfSignificantAccountingPoliciesLineItems_DF1BB22D3586CFBBF3D543510CF1303B" xlink:type="locator" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_vnda_SummaryOfSignificantAccountingPoliciesTable_D0F23350F161BBF675C343510CF11E48" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesLineItems_DF1BB22D3586CFBBF3D543510CF1303B" xlink:to="loc_vnda_SummaryOfSignificantAccountingPoliciesTable_D0F23350F161BBF675C343510CF11E48" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_461C0670F1AE577C261243510CF1324A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesTable_D0F23350F161BBF675C343510CF11E48" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_461C0670F1AE577C261243510CF1324A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_603FFF09A70035D316D343510CF1D429_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_461C0670F1AE577C261243510CF1324A" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_603FFF09A70035D316D343510CF1D429_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_603FFF09A70035D316D343510CF1D429" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_461C0670F1AE577C261243510CF1324A" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_603FFF09A70035D316D343510CF1D429" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_C514FFBEE4644A77B11C43510CF19D4B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_603FFF09A70035D316D343510CF1D429" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_C514FFBEE4644A77B11C43510CF19D4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_C088583EB82ECAA081E243510CF11108" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_603FFF09A70035D316D343510CF1D429" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_C088583EB82ECAA081E243510CF11108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5DC1899C6745D7CDEAB443510CF1ADF5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesTable_D0F23350F161BBF675C343510CF11E48" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5DC1899C6745D7CDEAB443510CF1ADF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9BC5690A4952DFE79C3A43510CF1CB0F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5DC1899C6745D7CDEAB443510CF1ADF5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9BC5690A4952DFE79C3A43510CF1CB0F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9BC5690A4952DFE79C3A43510CF1CB0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5DC1899C6745D7CDEAB443510CF1ADF5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9BC5690A4952DFE79C3A43510CF1CB0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_A12102EF3A02FB3C9D7B43510CF15AF3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9BC5690A4952DFE79C3A43510CF1CB0F" xlink:to="loc_us-gaap_SalesRevenueNetMember_A12102EF3A02FB3C9D7B43510CF15AF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_8FC5CDD193E1BC73492743510CF1D035" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9BC5690A4952DFE79C3A43510CF1CB0F" xlink:to="loc_us-gaap_AccountsReceivableMember_8FC5CDD193E1BC73492743510CF1D035" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_NumberOfMajorCustomersAccountedForRevenue" xlink:label="loc_vnda_NumberOfMajorCustomersAccountedForRevenue_4D1B0F675F0EDF2966CB43510CF19743" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesLineItems_DF1BB22D3586CFBBF3D543510CF1303B" xlink:to="loc_vnda_NumberOfMajorCustomersAccountedForRevenue_4D1B0F675F0EDF2966CB43510CF19743" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_35A1A2F586DD2EB34BF243510CF19B32" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesLineItems_DF1BB22D3586CFBBF3D543510CF1303B" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_35A1A2F586DD2EB34BF243510CF19B32" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_NumberOfMajorCustomersAccountedForTradeAccountsReceivable" xlink:label="loc_vnda_NumberOfMajorCustomersAccountedForTradeAccountsReceivable_97D0172A0FB9D2C27ED943510CF1DC68" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesLineItems_DF1BB22D3586CFBBF3D543510CF1303B" xlink:to="loc_vnda_NumberOfMajorCustomersAccountedForTradeAccountsReceivable_97D0172A0FB9D2C27ED943510CF1DC68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_EBF6A4E7817DB154EF6843510CF14FB8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vnda_SummaryOfSignificantAccountingPoliciesLineItems_DF1BB22D3586CFBBF3D543510CF1303B" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_EBF6A4E7817DB154EF6843510CF14FB8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesNetSalesByProductDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_19FCA447B4E8EF50FA30DDB18687E987" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_E1A22673E294A47E25DDDDB18686F738" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_19FCA447B4E8EF50FA30DDB18687E987" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_E1A22673E294A47E25DDDDB18686F738" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_8AB6F9EC92E53E2DB76BDDB18686E591" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_E1A22673E294A47E25DDDDB18686F738" xlink:to="loc_srt_ProductOrServiceAxis_8AB6F9EC92E53E2DB76BDDB18686E591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E640E35EA09A5033E7F2DDB18686E752_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8AB6F9EC92E53E2DB76BDDB18686E591" xlink:to="loc_srt_ProductsAndServicesDomain_E640E35EA09A5033E7F2DDB18686E752_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E640E35EA09A5033E7F2DDB18686E752" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8AB6F9EC92E53E2DB76BDDB18686E591" xlink:to="loc_srt_ProductsAndServicesDomain_E640E35EA09A5033E7F2DDB18686E752" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_HetliozMember" xlink:label="loc_vnda_HetliozMember_F8D3DDEC382604500F44DDB186869DF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_E640E35EA09A5033E7F2DDB18686E752" xlink:to="loc_vnda_HetliozMember_F8D3DDEC382604500F44DDB186869DF8" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_FanaptMember" xlink:label="loc_vnda_FanaptMember_57FF1F1517FB48BA81A4DDB186877890" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_E640E35EA09A5033E7F2DDB18686E752" xlink:to="loc_vnda_FanaptMember_57FF1F1517FB48BA81A4DDB186877890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_486AFEA63BBFF88D0352DDB186878CAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_19FCA447B4E8EF50FA30DDB18687E987" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_486AFEA63BBFF88D0352DDB186878CAC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5F07FF30057427743F68DDB18598B66F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_F1A4A0D6B2D0A3AA63A2DDB18596ABD1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5F07FF30057427743F68DDB18598B66F" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_F1A4A0D6B2D0A3AA63A2DDB18596ABD1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AB5E7ACA8B4EE65BEB9FDDB18597F4F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_F1A4A0D6B2D0A3AA63A2DDB18596ABD1" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AB5E7ACA8B4EE65BEB9FDDB18597F4F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_E735303BF126761ECB28DDB185978C06_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AB5E7ACA8B4EE65BEB9FDDB18597F4F2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_E735303BF126761ECB28DDB185978C06_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_E735303BF126761ECB28DDB185978C06" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AB5E7ACA8B4EE65BEB9FDDB18597F4F2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_E735303BF126761ECB28DDB185978C06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_68F16D055F63B6F2ED02DDB185974453" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_E735303BF126761ECB28DDB185978C06" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_68F16D055F63B6F2ED02DDB185974453" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_02FAFD1D9EFEF4B42BB4DDB185987987" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5F07FF30057427743F68DDB18598B66F" xlink:to="loc_us-gaap_OperatingLeaseLiability_02FAFD1D9EFEF4B42BB4DDB185987987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_162EA6688F3FE755BDD0DDB18598F966" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5F07FF30057427743F68DDB18598B66F" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_162EA6688F3FE755BDD0DDB18598F966" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6B2B1ED13298C51CDE55DDB185993D0C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5F07FF30057427743F68DDB18598B66F" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6B2B1ED13298C51CDE55DDB185993D0C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesSupplementalCashFlowsInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6FDF92755A20F1A88D4BDDB186A22591" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_465105899D4A01473094DDB186A1C9CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6FDF92755A20F1A88D4BDDB186A22591" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_465105899D4A01473094DDB186A1C9CF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_F061B077236FEE56E851DDB186A172AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_465105899D4A01473094DDB186A1C9CF" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_F061B077236FEE56E851DDB186A172AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_203D5FE11CA174C74C5ADDB186A278FD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_F061B077236FEE56E851DDB186A172AB" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_203D5FE11CA174C74C5ADDB186A278FD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_203D5FE11CA174C74C5ADDB186A278FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_F061B077236FEE56E851DDB186A172AB" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_203D5FE11CA174C74C5ADDB186A278FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8088C906904D339C8DF5DDB186A2C0B1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_203D5FE11CA174C74C5ADDB186A278FD" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8088C906904D339C8DF5DDB186A2C0B1" xlink:type="arc" />
    <link:loc xlink:href="vnda-20190630.xsd#vnda_NoncurrentInventoryAndOtherMember" xlink:label="loc_vnda_NoncurrentInventoryAndOtherMember_DD64EAA7456ED1A704F1DDB186A2C6E6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_203D5FE11CA174C74C5ADDB186A278FD" xlink:to="loc_vnda_NoncurrentInventoryAndOtherMember_DD64EAA7456ED1A704F1DDB186A2C6E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1802BA6A2DE9586DD41CDDB186A242CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6FDF92755A20F1A88D4BDDB186A22591" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1802BA6A2DE9586DD41CDDB186A242CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_E0041996BE2902016CD3DDB186A30BEF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6FDF92755A20F1A88D4BDDB186A22591" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_E0041996BE2902016CD3DDB186A30BEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_299E8E798998226480C3DDB186A3F82C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_E0041996BE2902016CD3DDB186A30BEF" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_299E8E798998226480C3DDB186A3F82C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50E9A1921924C05C609FDDB186A31C59" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6FDF92755A20F1A88D4BDDB186A22591" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50E9A1921924C05C609FDDB186A31C59" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.vandapharmaceuticals.com/role/Tables" xlink:type="extended" />
</link:linkbase>